| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $118.9M | -1.5% |
| SG&A Expense | $52.3M | +6.6% |
| Operating Income | -$171.2M | -0.8% |
| Pre-tax Income | -$169.0M | +1.2% |
| Income Tax | -$265K | -126.3% |
| Net Income | -$168.7M | +1.9% |
| EPS (Basic) | -$2.20 | +19.7% |
| EPS (Diluted) | -$2.20 | +19.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $106.1M | -47.4% |
| Short-term Investments | $127.7M | +174.9% |
| Current Assets | $243.1M | -4.1% |
| Total Assets | $277.1M | -3.3% |
| Current Liabilities | $24.3M | -35.7% |
| Total Liabilities | $52.6M | -14.3% |
| Stockholders' Equity | $224.5M | -0.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$142.1M | -33.6% |
| Capital Expenditures | $26K | +0.0% |
| Investing Cash Flow | -$80.5M | -143.3% |
| Financing Cash Flow | $127.0M | — |
| Free Cash Flow | -$142.1M | -33.6% |